Numeta G13E Emulsion for infusion
PDF Leaflet Revision Date: 23 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Parenteral nutrition in preterm newborn infants.
Dosage (summary)
Dosage depends on energy needs; max 5.1 ml/kg/h for 240 ml bag, 6.4 ml/kg/h for 300 ml bag.
Special Populations
- Renal impairment
- Hepatic impairment
Key Drug Interactions
- Ceftriaxone
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to egg, soy, or peanut proteins
- Congenital amino acid metabolism disorders
- Severe hyperglycaemia
Common side effects
- Hypophosphataemia
- Hyperglycaemia
- Hypercalcaemia
- Hypertriglyceridaemia
Counselling Points
- Monitor for signs of infection
- Avoid light exposure
- Do not add other medications without compatibility check
Serious warnings
- Risk of allergic reactions
- Pulmonary vascular precipitates
- Fat overload syndrome
Important Disclaimer
The Numeta G13E Emulsion for infusion professional information leaflet below is the property of Baxter Healthcare South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
